- Piramal Life may develop TB drug with leads from Antarctica - Business Standard
- Piramal Life Sciences gets listed at BSE - Business Standard
- Piramal receives green signal for clinical trial of two drugs - Business Standard
- Nicholas Piramal seeks strategic partner in new research firm - Livemint
- Nicholas Piramal may offer research arm stake to PEs - Economic Times
Piramal Life defers fund-raising plans - Business Standard
Piramal Life defers fund-raising plansBusiness Standard, India - 11 hours agoUnlike most other drug research companies in India, Nicholas Piramal plans to take forward its drugs as far as close to the commercialisation stage. ...Piramal puts plans for selling stake in R&D firm on hold Financial Expressall 2 news articles
